Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03098836
Title Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Daniel George, MD
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Apalutamide + Prednisone

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Tulane University New Orleans Louisiana 70112 United States Details
Chesapeake Urology Associates Baltimore Maryland 21204 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Duke Cancer Center Cary Cary North Carolina 27518 United States Details
UNC Lineberger Cancer Center Chapel Hill North Carolina 27514 United States Details
Johnston Hematology and Oncology of Clayton Clayton North Carolina 27520 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Maria Parham Hospital Henderson North Carolina 27536 United States Details
Scotland Memorial Hospital Laurinburg North Carolina 28352 United States Details
Southeastern Regional Lumberton North Carolina 28358 United States Details
Johnston Memorial Hospital Smithfield North Carolina 27577 United States Details
Spartanburg Regional Spartanburg South Carolina 29303 United States Details
Virginia Oncology Associates Hampton Virginia 29303 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field